Clinical trial
A 4 Week Study of Elidel (Pimecrolimus) for the Treatment of Seborrheic…
NCT00403559 · Dermatology Specialists Research, Other · Completed
Key facts
| NCT number | NCT00403559 |
|---|---|
| Title | A 4 Week Study of Elidel (Pimecrolimus) for the Treatment of Seborrheic Dermatitis |
| Official title | A 4 Week Randomized Double-blind Parallel Group Active Comparator Controlled Study of Elidel (Pimecrolimus) for the Treatment of Seborrheic Dermatitis |
| Lead sponsor | Dermatology Specialists Research, Other |
| Collaborators | Novartis Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Seborrheic Dermatitis |
| Intervention type | Drug |
| Interventions | Elidel, Ketoconazole Cream |
| Enrollment | 113 |
| Start date | May 7, 2007 |
| Primary completion | Feb 20, 2009 |
| Completion | Feb 27, 2009 |
| First posted | Nov 23, 2006 |
| Last update posted | Mar 14, 2022 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: